home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Biosimilars & Biobetters Congress

 
  October 07, 2015  
     
 
Oxford Global Conferences, Novotel London West
18-19 April 2016


To download the Congress agenda to view the programme in full, please visit http://www.biosimilars-congress.com/download-agenda-marketing/
 
 
Organized by: OxfordGlobal
Invited Speakers:
  • Ali Atta
    Head of Compliance, Takeda
  • Hubert Chen
    Chief Medical Officer, Pfenex
  • Anna Cyranka
    Bioassays Coordinator, Polpharma Biologics
  • Rakesh Dixit
    Vice President, R & D; Global Head Biologics Safety Assessment, Patholoy & LAR, MedImmune
  • Atanas Dmitrox
    Head of Strategy & Portfolio Management, Merck
  • Katalin Egyed
    International Oncology and Oncobiotechnology Business Unit Manager, Egis Pharmaceuticals
  • Mourad Farouk
    Global Head Medical Affairs Biosimilars, Biogen Idec
  • Uwe Gudat
    Head of Medical Safety, Biosimilars, Merck Serono
  • Zsolt Holló
    Head, Biologics Advisory, Egis Pharmaceuticals
  • Roman Ivanov
    Vice President, Research & Development, Biocad
  • Alex Kudrin
    Vice President & Head, Global Development, Celltrion
  • Michael Leach
    Therapeutic Area Lead – Biosimilars and Centres for Therapeutic Innovation, Pfizer
  • Emmanuelle Lepine
    Vice President Business Development Biosimilars, Alvotech
  • Bernd Liedert
    Program Director Biosimilars and Strategic Advisor for Extrapolation, Boehringer Ingelheim
  • Steinar Madsen
    Medical Director, Norwegian Medicines Agency
  • Leandro Mieravilla
    Global Commercial Manager, Cassara Biotech
  • Julie O'Brien
    Senior Manager, Emerging Markets Regulatory Policy, Worldwide Safety Regulatory, Pfizer
  • Devrim Satik
    Head of Regulatory Affairs & Product Patrimony, Sanofi
  • Ozdemir Sengoeren
    Managing Director - Turkey, Middle East & Africa, UCB
  • Meenu Wadhwa
    Section Leader, Ctyokines & Growth Factors, NIBSC
  • Keith Watson
    Director Biotherapeutics & Biosimilars, Abbvie
  • Atakan Yesil
    Market Development & Reimbursement Manager, Abbott
 
Deadline for Abstracts: TBC
 
Registration: For further information regarding prices and available discounts, please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or call +44 (0)1865 248455
E-mail: d.dalby@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.